Order Article Reprints

Monane M, Maraganore DM, Carlile RM, Johnson KG, Merrill DA, Gitelman DR, Sharlin KS, VandeVrede LA, George KK, Wang J, et al. Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study. Diagnostics. 2025; 15(2):167. https://doi.org/10.3390/diagnostics15020167

Monane, Mark, Demetrius M. Maraganore, Robert M. Carlile, Kim G. Johnson, David A. Merrill, Darren R. Gitelman, Kenneth S. Sharlin, Lawren A. VandeVrede, Kristi K. George, Jimin Wang, and et al. 2025. "Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study" Diagnostics 15, no. 2: 167. https://doi.org/10.3390/diagnostics15020167

Monane, M., Maraganore, D. M., Carlile, R. M., Johnson, K. G., Merrill, D. A., Gitelman, D. R., Sharlin, K. S., VandeVrede, L. A., George, K. K., Wang, J., West, T., Jacobs, L., Verghese, P. B., & Braunstein, J. B. (2025). Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study. Diagnostics, 15(2), 167. https://doi.org/10.3390/diagnostics15020167